183 related articles for article (PubMed ID: 16996476)
1. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
Christoph T; Grünweller A; Mika J; Schäfer MK; Wade EJ; Weihe E; Erdmann VA; Frank R; Gillen C; Kurreck J
Biochem Biophys Res Commun; 2006 Nov; 350(1):238-43. PubMed ID: 16996476
[TBL] [Abstract][Full Text] [Related]
2. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
[TBL] [Abstract][Full Text] [Related]
3. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats.
Kanai Y; Nakazato E; Fujiuchi A; Hara T; Imai A
Neuropharmacology; 2005 Dec; 49(7):977-84. PubMed ID: 15998524
[TBL] [Abstract][Full Text] [Related]
4. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1.
Christoph T; Gillen C; Mika J; Grünweller A; Schäfer MK; Schiene K; Frank R; Jostock R; Bahrenberg G; Weihe E; Erdmann VA; Kurreck J
Neurochem Int; 2007 Jan; 50(1):281-90. PubMed ID: 17045702
[TBL] [Abstract][Full Text] [Related]
7. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
[TBL] [Abstract][Full Text] [Related]
8. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
Sándor K; Helyes Z; Elekes K; Szolcsányi J
Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.
Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ
Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
13. Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice.
Christoph T; Bahrenberg G; De Vry J; Englberger W; Erdmann VA; Frech M; Kögel B; Röhl T; Schiene K; Schröder W; Seibler J; Kurreck J
Mol Cell Neurosci; 2008 Mar; 37(3):579-89. PubMed ID: 18249134
[TBL] [Abstract][Full Text] [Related]
14. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.
Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P
J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028
[TBL] [Abstract][Full Text] [Related]
15. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
17. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat.
van den Wijngaard RM; Welting O; Bulmer DC; Wouters MM; Lee K; de Jonge WJ; Boeckxstaens GE
Neurogastroenterol Motil; 2009 Aug; 21(8):863-e60. PubMed ID: 19298229
[TBL] [Abstract][Full Text] [Related]
18. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
Winston J; Shenoy M; Medley D; Naniwadekar A; Pasricha PJ
Gastroenterology; 2007 Feb; 132(2):615-27. PubMed ID: 17258716
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat.
Kasama S; Kawakubo M; Suzuki T; Nishizawa T; Ishida A; Nakayama J
Eur J Neurosci; 2007 May; 25(10):2956-63. PubMed ID: 17509082
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
Phelps PT; Anthes JC; Correll CC
Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
